Live News EQUITY FLASH L impact Oct 27, 2026, 06:04 AM UTC Idorsia DARI-DREAM Phase 3 Study to Randomize 344 Participants The DARI-DREAM Phase 3 study will randomize 344 participants to QUVIVIQ 50 mg or placebo. SquawkNews Desk